BioMarin Pharmaceutical Inc. (BMRN) Quarterly Income Statement

120+ quarters historyFree accessUpdated daily

BioMarin Pharmaceutical Inc. (BMRN) quarterly income statement — complete revenue, gross profit & net income history

Quarterly statement

BMRN Income Statement

BioMarin Pharmaceutical Inc. (BMRN) annual income statement — 28-year revenue, gross profit & net income history

Metric	Q3'26	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24	Q1'24	Q4'23	Q3'23	Q2'23	Q1'23	Q4'22	Q3'22	Q2'22	Q1'22	Q4'21

Sales/Revenue	1.02B	989.71M	766.21M	874.57M	776.13M	825.41M	745.14M	747.31M	745.74M	712.03M	648.83M	646.21M	581.33M	595.27M	596.41M	537.54M	505.34M	533.8M	519.36M	449.81M
Revenue Growth %	32.02%	19.91%	2.83%	17.03%	4.08%	15.92%	14.84%	15.65%	28.28%	19.61%	8.79%	20.22%	15.04%	11.52%	14.84%	19.5%	23.63%	6.4%	6.86%	-0.51%
Cost of Goods Sold	205.42M	202.79M	195M	295.1M	140.09M	150.09M	151.56M	136.14M	188.46M	130.46M	125.18M	135.48M	128.04M	130.62M	135.47M	127.29M	116.29M	123.13M	116.97M	119.75M
COGS % of Revenue	20.05%	20.49%	25.45%	33.74%	18.05%	18.18%	20.34%	18.22%	25.27%	18.32%	19.29%	20.97%	22.03%	21.94%	22.71%	23.68%	23.01%	23.07%	22.52%	26.62%
Gross Profit	819.23M	786.91M	571.21M	579.47M	636.05M	675.32M	593.59M	611.17M	557.28M	581.57M	523.65M	510.73M	453.29M	464.66M	460.94M	410.25M	389.06M	410.67M	402.39M	330.06M
Gross Margin %	79.95%	79.51%	74.55%	66.26%	81.95%	81.82%	79.66%	81.78%	74.73%	81.68%	80.71%	79.03%	77.97%	78.06%	77.29%	76.32%	76.99%	76.93%	77.48%	73.38%
Gross Profit Growth %	28.8%	16.52%	-3.77%	-5.19%	14.13%	16.12%	13.36%	19.67%	22.94%	25.16%	13.6%	24.49%	16.51%	13.15%	14.55%	24.3%	27.47%	9.62%	9.98%	1.25%
Operating Expenses	901.31M	675.98M	441.58M	500.08M	682.74M	398.43M	369.69M	449.77M	443.39M	461.12M	435.19M	496.51M	422.76M	399.09M	398.54M	434.75M	391.47M	371.52M	265.07M	395.94M
OpEx % of Revenue	87.96%	68.3%	57.63%	57.18%	87.97%	48.27%	49.61%	60.18%	59.46%	64.76%	67.07%	76.83%	72.72%	67.04%	66.82%	80.88%	77.47%	69.6%	51.04%	88.02%
Selling, General & Admin	333.64M	395.54M	258.3M	802.12M	268.42M	232.3M	206.1M	266.6M	253.5M	263M	225.9M	275M	172.6M	206.1M	211.02M	245.71M	216.8M	196.84M	194.62M	217.6M
SG&A % of Revenue	32.56%	39.97%	33.71%	91.72%	34.58%	28.14%	27.66%	35.67%	33.99%	36.94%	34.82%	42.56%	29.69%	34.62%	35.38%	45.71%	42.9%	36.87%	37.47%	48.38%
Research & Development	180.53M	206.95M	178.8M	192.41M	409.48M	161.31M	158.73M	173.51M	184.9M	183.79M	204.99M	206.25M	191.31M	177.36M	171.85M	172.75M	157.83M	158.19M	160.84M	161.09M
R&D % of Revenue	17.62%	20.91%	23.34%	22%	52.76%	19.54%	21.3%	23.22%	24.79%	25.81%	31.59%	31.92%	32.91%	29.8%	28.81%	32.14%	31.23%	29.63%	30.97%	35.81%
Other Operating Expenses	1000K	1000K	1000K	-1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	1000K	-1000K	1000K
Operating Income	-82.08M	110.93M	129.63M	79.39M	-46.69M	276.89M	223.89M	161.41M	113.89M	120.45M	88.46M	14.22M	30.52M	65.57M	62.4M	-24.5M	-2.42M	39.15M	137.33M	-65.88M
Operating Margin %	-8.01%	11.21%	16.92%	9.08%	-6.02%	33.55%	30.05%	21.6%	15.27%	16.92%	13.63%	2.2%	5.25%	11.01%	10.46%	-4.56%	-0.48%	7.33%	26.44%	-14.65%
Operating Income Growth %	-75.79%	-59.94%	-42.1%	-50.81%	-141%	129.87%	153.1%	1035.15%	273.11%	83.71%	41.76%	158.04%	1362.93%	67.47%	-54.56%	62.81%	95.46%	235.44%	447.42%	-46.92%
EBITDA	48.38M	208.57M	146.04M	99.83M	-28.2M	295.45M	245.96M	185.01M	132.9M	146.91M	115.81M	41.08M	56.21M	90.98M	88.83M	53K	22.39M	64.42M	164.67M	-39.89M
EBITDA Margin %	4.72%	21.07%	19.06%	11.41%	-3.63%	35.79%	33.01%	24.76%	17.82%	20.63%	17.85%	6.36%	9.67%	15.28%	14.89%	0.01%	4.43%	12.07%	31.71%	-8.87%
EBITDA Growth %	271.54%	-29.41%	-40.62%	-46.04%	-121.22%	101.1%	112.38%	350.37%	136.43%	61.47%	30.38%	77409.43%	151.11%	41.23%	-46.06%	100.13%	184.86%	65.6%	210.29%	-128.2%
D&A (Non-Cash Add-back)	130.47M	97.64M	16.41M	20.44M	18.49M	18.56M	22.07M	23.61M	19.01M	26.46M	27.35M	26.86M	25.68M	25.42M	26.42M	24.55M	24.8M	25.27M	27.34M	25.99M
EBIT	-76.14M	124.68M	156.16M	-24.38M	-23.75M	300.55M	240.95M	171.89M	137.41M	135.71M	109.09M	24.83M	45.45M	74.56M	60.46M	-14.53M	2.77M	38.71M	137.99M	-63.32M
Net Interest Income	-51M	-52.81M	7.6M	16.43M	15.28M	16.15M	16.15M	15.04M	15.09M	16.21M	15.82M	11.95M	11.96M	8.86M	8.24M	5.08M	320K	-1.35M	-1.99M	-2.1M
Interest Income	4.63M	10.48M	22.56M	19.21M	17.85M	18.83M	19.01M	17.68M	18.05M	19.79M	19.36M	18.04M	15.74M	12.61M	11.94M	8.71M	5M	2.5M	1.82M	1.75M
Interest Expense	55.63M	63.3M	14.96M	2.78M	2.58M	2.68M	2.86M	2.58M	2.97M	3.57M	3.55M	6.1M	3.78M	3.75M	3.7M	3.63M	4.68M	3.86M	3.81M	3.85M
Other Income/Expense	-49.69M	-49.55M	11.57M	-106.54M	20.37M	20.98M	14.2M	8.23M	20.55M	11.68M	17.09M	5.11M	11.14M	5.24M	-5.65M	6.94M	513K	-4.3M	-3.14M	-694K
Pretax Income	-131.77M	61.38M	141.2M	-27.15M	-26.32M	297.87M	238.09M	169.64M	134.44M	132.14M	105.55M	19.33M	41.67M	70.81M	56.76M	-17.56M	-1.9M	34.85M	134.19M	-66.57M
Pretax Margin %	-12.86%	6.2%	18.43%	-3.1%	-3.39%	36.09%	31.95%	22.7%	18.03%	18.56%	16.27%	2.99%	7.17%	11.9%	9.52%	-3.27%	-0.38%	6.53%	25.84%	-14.8%
Income Tax	-8.94M	16.62M	35.68M	19.42M	4.42M	57.34M	52.4M	44.7M	28.36M	24.96M	16.89M	-1.05M	1.29M	14.77M	5.91M	-17.31M	4.75M	7.19M	13.39M	-8.68M
Effective Tax Rate %	6.78%	27.08%	25.27%	-71.52%	-16.79%	19.25%	22.01%	26.35%	21.1%	18.89%	16%	-5.42%	3.1%	20.86%	10.4%	98.58%	-249.37%	20.62%	9.98%	13.03%
Net Income	-122.83M	44.76M	105.53M	-46.57M	-30.74M	240.53M	185.69M	124.94M	106.08M	107.17M	88.66M	20.38M	40.38M	56.04M	50.85M	-249K	-6.65M	27.66M	120.8M	-57.9M
Net Margin %	-11.99%	4.52%	13.77%	-5.33%	-3.96%	29.14%	24.92%	16.72%	14.22%	15.05%	13.66%	3.15%	6.95%	9.41%	8.53%	-0.05%	-1.32%	5.18%	23.26%	-12.87%
Net Income Growth %	-299.53%	-81.39%	-43.17%	-137.28%	-128.98%	124.43%	109.43%	513.22%	162.72%	91.25%	74.35%	8282.73%	707.01%	102.57%	-57.9%	99.57%	81.77%	113.77%	595.4%	-361.99%
Net Income (Continuing)	-122.83M	44.76M	105.53M	-46.57M	-30.74M	240.53M	185.69M	124.94M	106.08M	107.17M	88.66M	20.38M	40.38M	56.04M	50.85M	-249K	-6.65M	27.66M	120.8M	-57.9M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)	-0.63	0.23	0.54	-0.22	-0.16	1.23	0.95	0.64	0.55	0.55	0.46	0.11	0.21	0.29	0.26	-0.00	-0.04	0.15	0.62	-0.32
EPS Growth %	-293.75%	-81.3%	-43.16%	-134.38%	-129.09%	123.64%	106.52%	481.82%	161.9%	89.66%	76.92%	-	686.59%	93.33%	-58.06%	99.59%	82.1%	114.29%	588.89%	-366.67%
EPS (Basic)	-0.63	0.23	0.55	-0.24	-0.16	1.25	0.97	0.66	0.57	0.56	0.47	0.11	0.21	0.30	0.27	-0.00	-0.04	0.15	0.63	-0.32
Diluted Shares Outstanding	193.59M	194.15M	197.67M	197.39M	192.03M	196.64M	196.47M	196.58M	197.15M	200.5M	199.26M	191.84M	191.17M	195M	194.36M	186.03M	185.6M	187.45M	194.89M	183.55M
Basic Shares Outstanding	193.59M	192.96M	192.5M	191.79M	192.03M	191.44M	190.97M	190.69M	190.43M	190.11M	188.87M	188.48M	188.22M	187.95M	186.67M	186.03M	185.6M	185.25M	190.53M	181.6M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-